MLchartDataset catalogue

CDK inhibitor SCH 727965

Term · Oncology and biomedicine · MLC-T-ONC-001537

A substance being studied in the treatment of advanced melanoma (a type of skin cancer) and other types of cancer. It blocks cell division and may cause cancer cells to die. It is a type of cyclin-dependent kinase inhibitor. Also called dinaciclib.

Table 1. Record
IdentifierMLC-T-ONC-001537
FieldOncology and biomedicine
Synonymsdinaciclib
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-001537",
  "term": "CDK inhibitor SCH 727965",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of advanced melanoma (a type of skin cancer) and other types of cancer. It blocks cell division and may cause cancer cells to die. It is a type of cyclin-dependent kinase inhibitor. Also called dinaciclib.",
  "synonyms": [
    "dinaciclib"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/cdk-inhibitor-sch-727965/"
}

Record 4,464 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.